Activation of Keap1/Nrf2 signaling exerts beneficial effects in numerous disease states including atherosclerosis, diabetes, liver injury, malaria, obesity, neurodegenerative diseases and certain cancers23–25. Here, NFE2L2 is linked to obesity due to melanocortin 4 receptor deficiency.